73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
H. pylori treatment may reduce gastric cancer incidence, death

H. pylori treatment may reduce gastric cancer incidence, death

(HealthDay)—Helicobacter pyloritreatment, vitamin supplementation, and garlic supplementation are associated with a reduced risk for gastric cancer mortality, according to a study published onli

H. pylori treatment may reduce gastric cancer incidence, death

(HealthDay)—Helicobacter pyloritreatment, vitamin supplementation, and garlic supplementation are associated with a reduced risk for gastric cancer mortality, according to a study published onli
Once shelved as too risky, blood cancer drug discovered in San Diego gets FDA approval

Once shelved as too risky, blood cancer drug discovered in San Diego gets FDA approval

by Bradley J. FikesCancer cell during cell division. Credit: National Institutes of HealthA promising cancer drug, discovered in San Diego and later discarded for safety concerns, has at last been app

Once shelved as too risky, blood cancer drug discovered in San Diego gets FDA approval

by Bradley J. FikesCancer cell during cell division. Credit: National Institutes of HealthA promising cancer drug, discovered in San Diego and later discarded for safety concerns, has at last been app
Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with
Radiation therapy for patients with breast cancer explained

Radiation therapy for patients with breast cancer explained

by Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainRadiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells

Radiation therapy for patients with breast cancer explained

by Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainRadiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells
Two-pronged immunotherapy eliminates metastatic breast cancer in mice

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer
Researchers discover possible new treatment for triple-negative breast cancer

Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene

Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene
Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

byInstitute of Cancer ResearchImmunofluorescent image of autophagosomes in multiple myeloma cells. Credit: Institute of Cancer ResearchCombining five existing drugs can keep a highly aggressive

Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

byInstitute of Cancer ResearchImmunofluorescent image of autophagosomes in multiple myeloma cells. Credit: Institute of Cancer ResearchCombining five existing drugs can keep a highly aggressive
Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

by University of North Carolina at Chapel Hill School of MedicineBhisham Chera, MD. Credit: University of North Carolina at Chapel Hill School of MedicineUniversity of North Carolina Lineberger C

Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

by University of North Carolina at Chapel Hill School of MedicineBhisham Chera, MD. Credit: University of North Carolina at Chapel Hill School of MedicineUniversity of North Carolina Lineberger C
Study tests new vaccine for precancerous cervical cells

Study tests new vaccine for precancerous cervical cells

by Kelsey Herbers,Vanderbilt UniversityCredit: CC0 Public DomainVanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeuti

Study tests new vaccine for precancerous cervical cells

by Kelsey Herbers,Vanderbilt UniversityCredit: CC0 Public DomainVanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeuti
What causes breast cancer?

What causes breast cancer?

by Annika Lund,Karolinska InstitutetMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaThere is a lot

What causes breast cancer?

by Annika Lund,Karolinska InstitutetMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaThere is a lot
Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma
A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C